Lexicon Pharmaceuticals
LXRX
#6851
Rank
S$0.95 B
Marketcap
S$2.15
Share price
-4.55%
Change (1 day)
11.35%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): S-$0.19

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.19. In 2025 the company made an earnings per share (EPS) of S-$0.18 an increase over its 2024 EPS that were of S-$0.82.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.197.98%
2025S-$0.18-78.13%
2024S-$0.82-20%
2023S-$1.0231.15%
2022S-$0.78-0%
2021S-$0.7810.91%
2020S-$0.70-145.08%
2019S$1.56-206.09%
2018S-$1.47-5.74%
2017S-$1.56-10.95%
2016S-$1.752640%
2015S-$0.06402-96.34%
2014S-$1.75-2.53%
2013S-$1.79-9.09%
2012S-$1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$23.84-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$6.93-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$53.66-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.48 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$12.82-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.02561-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.96 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$37.50 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA